Description
The Access SARS-CoV-2 IgG II assay is a semi-quantitative and qualitative immunoassay that measures IgG antibodies directed to the receptor-binding domain of the spike protein of the novel coronavirus in response to a previous infection. The assay then provides a numerical result ranging from 2.00-450/mL1 as well as a qualitative result for SARS-CoV-2 IgG antibodies and can be used in Random Access Mode (RAM) as well as seamlessly integrated into existing workflows without batch processing.
Request Information
Specifications
• Assay Format: 2x100 determinations
• Calibrator Format: S0-S5, 1 vial/kit, 2mL/vial
• QC Format: QC1-QC2, 3 vials/kit, 4mL/vial
• Sample volume: 20uL
• Open pack stability: 28 days
• Calibration stability: 28 days
• Time-to-first result (approx.): 32 minutes
Request Information